Showing 41-50 of 2779 results for "".
Safety Monitoring of Disease-Modifying Therapies in Multiple Sclerosis
https://practicalneurology.com/programs/practical-neurology/safety-monitoring-of-disease-modifying-therapies-in-multiple-sclerosis/31262/Aisha Elfasi, MD, Clinical and Research Fellow, Department of Neurology, Johns Hopkins University, provides an overview of the currently available disease-modifying therapies for multiple sclerosis, highlighting important safety considerations and routine monitoring requirements.SMA Experience: Episode 1
https://practicalneurology.com/diseases-diagnoses/neuromuscular/sma-experiences/30080/Neuromuscular disease expert Charlotte Sumner, MD chats with her patient Nicole Moore about some of her life goals and how recent treatment options have changed the conversations between them.Factors Influencing the Selection of CSF Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-csf-tests-for-alzheimer-disease/35726/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of cerebrospinal fluid tests for Alzheimer disease.Ocrevus Treatment in Pregnant and Lactating Women with Multiple Sclerosis
https://practicalneurology.com/programs/practical-neurology/ocrevus-treatment-pregnant-lactating-women-with-multiple-sclerosis/35558/Riley Bove, MD, UCSF School of Medicine, San Francisco, CA details results from the MINORE and SOPRANINO studies examining Ocrevus treatment in pregnant and lactating women with multiple sclerosis.Narcolepsy, Idiopathic Hypersomnia, and General Sleep Disorders
https://practicalneurology.com/programs/practical-neurology/narcolepsy-idiopathic-hypersomnia-and-general-sleep-disorders/30083/In this episode, Rajkumar Dasgupta, MD, Clinical Associate Professor at Keck School of Medicine of USC and sleep specialist, provides an in-depth review of what's new in sleep disorders, with a special focus on updates in narcolepsy and idiopathic hypersomnia.Factors Influencing the Selection of Amyloid PET Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-amyloid-pet-tests-for-alzheimer-disease/37135/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of amyloid PET tests for Alzheimer disease.- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn-0707-dementia-pdf/31141/In the realm of dementia care, accurate CPT (Current Procedural Terminology) coding is crucial for appropriate reimbursement and reflecting the complexity of patient management. David S. Geldmacher, MD, addresses the challenges neurologists face when utilizing CPT codes for dementia evaluations in h
Cerebrovascular Inflammatory Conditions: Diagnostic Challenges and Treatment Considerations
https://practicalneurology.com/diseases-diagnoses/stroke/cerebrovascular-inflammatory-conditions-diagnostic-challenges-and-treatment-considerations/36478/Abbas Kharal, MD, MPH, Neurologist at Cleveland Clinic Neurological Institute, Cleveland, OH, provides a review of cerebrovascular inflammatory conditions, with an emphasis on diagnostic challenges, the evolving treatment landscape, and the use of imaging and clinical responses to assist clinicians- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0505PainManagement-pdf/31457/Interventional pain management procedures are increasingly integral to comprehensive neurological care, yet many neurologists without a chronic pain specialization may hesitate to adopt these techniques. Understanding the indications, benefits, and inherent risks of these procedures is crucial for e
Seeking Breakthroughs: The Startup Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-startup-perspective/30194/A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin Therapeutics